Bristol Myers Squibb (NYSE: BMY) recently reported its Q3 results, with revenues and earnings exceeding the street estimates.

German companies including Merck and ZEISS expressed strong confidence and high hopes for the Chinese market at the China ...

Vietnam Expands for 2025 with Addition of New Hall - The largest edition yet, nearly double the size of the 2023 edition. - ...

Korea will be home to the regional headquarters of both Hewlett-Packard and Vestas ... chief technology officer of the life ...

Pivotal Phase 3 trial (IOB-013/KN-D18) evaluating off-the-shelf therapeutic cancer vaccine IO102-IO103 in combination with Merck’s anti-PD-1 ...

The clinical trials are sponsored by IO Biotech and conducted in collaboration with Merck, which is supplying pembrolizumab ... IO Biotech is headquartered in Copenhagen, Denmark and has US ...

PhotonPay announced that it has become a Mastercard issuer in Hong Kong. The two parties will integrate their respective professional capabilities and resource advantages and work together to provide ...

(Nasdaq: GILD) announced today its third quarter 2024 results of operations. "Gilead’s third quarter results are the strongest of the year to date, with 7% year-over-year revenue growth, including 13% ...

"Many multinationals with headquarters in Pudong have also played a significant ... to seek synergies in various fields," she added. Marc Horn, president of Merck China, also spoke highly of China's ...

Islatravir is Merck's investigational nucleoside reverse transcriptase ... Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, Calif. For more than 35 years, Gilead ...

Biotheus’ antibody drug targets PD-L1 and VEGF, a design that’s high on drugmakers’ radars after the success of Summit ...